在患有1型糖尿病的年轻成年人中,日常体力活动和骨微型架构的关联 - - 一项试点探索性研究
Sarah L West1, Michelle Furman2, Rahim Moineddin3
1Department of Kinesiology, Trent University, Peterborough, ON, Canada.
Bone reports
|November 29, 2024
概括
中度至强度的体力活动 (MVPA) 显示了1型糖尿病 (T1D) 的年轻人与骨健康的非线性关联. 这表明,量身定制的运动可能会改善这个人群的骨状况.
科学领域:
- 内分泌学 在内分泌学.
- 整形外科 整形外科 整形外科
- 运动医学 运动医学
背景情况:
- 身体活动对于骨健康至关重要.
- 患有1型糖尿病 (T1D) 的年轻人面临骨折风险增加.
- 有限的研究存在于T1D的身体活动和骨健康.
研究的目的:
- 描述患有T1D的年轻成年人的体力活动水平.
- 调查身体活动与骨参数之间的关联.
- 使用高分辨率的外围定量计算断层扫描 (HR-pQCT) 进行骨评估.
主要方法:
- 试点横截面研究设计.
- HR-pQCT测量了远距离骨和半径的骨结果.
- 加速度计记录了每日轻度和中度至强度的体力活动 (MVPA).
主要成果:
- 19名患有T1D的年轻成年人 (平均年龄为23.1岁) 参加了这项研究.
- 63%的人达到建议的每周150分钟的MVPA.
- 观察到MVPA持续时间和椎骨参数之间存在显著的非线性关联.
结论:
- MVPA证明了T1D的年轻成年人与骨的位点特异性 (骨) 和隔间特异性 (骨) 非线性关联.
- 结果可能会为优化T1D骨健康的运动建议提供信息.
- 需要进一步的研究来证实这些关联.
更多相关视频
06:13Author Spotlight: Exploring the Impact of Reduced Resistance Exercise Volume on Metabolic Health
Published on: December 1, 2023
1.0K
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
199
相关概念视频
Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetic Nephropathy
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
